Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Graefes Arch Clin Exp Ophthalmol ; 259(4): 1035-1043, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33128673

RESUMEN

PURPOSE: To quantify a passive range of cyclorotation using a smartphone application and evaluate its associations with fundus torsion and rectus muscle cyclorotation in superior oblique palsy (SOP) and V-pattern strabismus. METHODS: Fifty-two patients showing overelevation in adduction (30 with congenital SOP and 22 with V-pattern strabismus) underwent forced cyclorotation on the photographs. A photograph of the globe was taken in maximally excyclorotated and incyclorotated positions after marking at the 6 and 12 o'clock limbus under general anaesthesia, and the rotational alignment of these markings was read using the toriCAM application. The degrees of forced cyclorotation were compared between the two groups. Disc-fovea angle on fundus photographs and rectus muscle cyclorotation in the coronal view on orbital computed tomography were correlated with the range of forced excyclorotation. RESULTS: The range of forced excyclorotation was greater in V-pattern strabismus than that in SOP (58.5° vs. 46.8°, p < 0.001), whereas the ranges of incyclorotation were similar between the two groups (39.0° vs. 39.0°, p = 0.543). Regression analysis revealed a significant increase in the range of excyclorotation with the degree of rectus muscle excyclorotation, after accounting for age and angle of hypertropia (r2 = 0.475, p = 0.001). The range of excyclorotation did not correlate with the amount of fundus extorsion and grade of overelevation in adduction. CONCLUSIONS: The range of excyclorotation was correlated with the rectus muscle excyclorotation in these populations, suggesting that the results from this forced cyclorotation test may reflect orbital alignment and oblique muscle status.


Asunto(s)
Estrabismo , Enfermedades del Nervio Troclear , Humanos , Músculos Oculomotores/diagnóstico por imagen , Procedimientos Quirúrgicos Oftalmológicos , Parálisis , Estudios Retrospectivos , Estrabismo/diagnóstico , Estrabismo/cirugía , Enfermedades del Nervio Troclear/diagnóstico
2.
J Diabetes Res ; 2019: 8164250, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31930145

RESUMEN

Diabetic macular edema (DME) is the abnormal accumulation of fluid in the subretinal or intraretinal spaces in the macula in patients with diabetic retinopathy and leads to severely impaired central vision. Technical developments in retinal imaging systems have led to many advances in the study of DME. In particular, optical coherence tomography (OCT) can provide longitudinal and microstructural analysis of the macula. A comprehensive review was provided regarding the role of inflammation using OCT-based classification of DME and current and ongoing therapeutic approaches. In this review, we first describe the pathogenesis of DME, then discuss the classification of DME based on OCT findings and the association of different types of DME with inflammation, and finally describe current and ongoing therapeutic approaches using OCT-based classification of DME. Inflammation has an important role in the pathogenesis of DME, but its role appears to differ among the DME phenotypes, as determined by OCT. It is important to determine how the different DME subtypes respond to intravitreal injections of steroids, antivascular endothelial growth factor agents, and other drugs to improve prognosis and responsiveness to treatment.


Asunto(s)
Retinopatía Diabética/clasificación , Inflamación/diagnóstico por imagen , Edema Macular/clasificación , Tomografía de Coherencia Óptica/métodos , Corticoesteroides/uso terapéutico , Retinopatía Diabética/diagnóstico por imagen , Retinopatía Diabética/etiología , Retinopatía Diabética/inmunología , Células Epiteliales/fisiología , Humanos , Edema Macular/diagnóstico por imagen , Edema Macular/etiología , Microglía/fisiología , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidores
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA